Study to Determine the Safety of Two Applications of PEP005 Topical Gel to Superficial Basal Cell Carcinoma

Dose-Ranging Clinical Trial of Topical Creams Containing API 31510 for the Treatment of Superficial Basal Cell Carcinoma

NCT00604890 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Study to Evaluate Safety, Efficacy of Intralesional Injection of STP705 in Patients With isSCC

NCT04844983 ·Status: COMPLETED ·Phase: PHASE2

Open-Label Proof of Concept Study of VP-315 in Basal Cell Carcinoma

NCT05188729 ·Status: COMPLETED ·Phase: PHASE2

A Study of the Efficacy and Safety of ASN-002 in Adult Patients With Low-risk Nodular Basal Cell Carcinoma

NCT02550678 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Safety and Efficacy Evaluation of AIV001 in Nonmelanoma Skin Cancer of the Low Risk Basal Cell Carcinoma Subtype

NCT04470726 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Phase 2 Study of OBP-301 (Telomelysin™) in Combination With Pembrolizumab and SBRT in Patients With HNSCC With Inoperable, Recurrent or Progressive Disease

NCT04685499 ·Status: TERMINATED ·Phase: PHASE2

To Evaluate the Safety, Local Tolerability, PK and PD of LDE225 on Sporadic Superficial and Nodular Skin Basal Cell Carcinomas (sBCC)

NCT01033019 ·Status: TERMINATED ·Phase: PHASE2

A Study of Vismodegib With Surgery in Participants With Previously Untreated Basal Cell Carcinoma

NCT01898598 ·Status: TERMINATED ·Phase: PHASE2

Dose-Ranging Safety and Efficacy Study of Topical Creams Containing API 31510 for the Treatment of in Situ Cutaneous Squamous Cell Carcinoma

NCT00605709 ·Status: WITHDRAWN ·Phase: PHASE2

A Study of Two Vismodegib Regimens in Participants With Multiple Basal Cell Carcinomas

NCT01815840 ·Status: COMPLETED ·Phase: PHASE2

Study of TVEC in Patients With Cutaneous Squamous Cell Cancer

NCT03714828 ·Status: COMPLETED ·Phase: PHASE2

Comparison of Liposomal Doxorubicin Used Alone or in Combination With Bleomycin Plus Vincristine in the Treatment of Kaposi's Sarcoma in Patients With AIDS

NCT00001059 ·Status: COMPLETED ·Phase: PHASE2

Trial Comparing the Effects of Intermittent Vismodegib vs. PDT in Patients With Multiple Basal Cell Carcinomas

NCT01556009 ·Status: COMPLETED ·Phase: PHASE2

Photodynamic Therapy Clinical Trial For Cutaneous AIDS-Related Kaposi's Sarcoma Study Summary.

NCT00002167 ·Status: COMPLETED ·Phase: PHASE2

Photodynamic Therapy in Treating Patients With Recurrent, Refractory, or Second Primary Head and Neck Cancer That Cannot Be Treated With Surgery or Radiation Therapy

NCT00003856 ·Status: UNKNOWN ·Phase: PHASE2

Study of ASN-002 to Treat Basal Cell Carcinomas (BCCs) in Individuals With Basal Cell Nevus Syndrome (BCNS)

NCT03208296 ·Status: SUSPENDED ·Phase: PHASE1/PHASE2

Carboplatin and Paclitaxel With or Without Sorafenib Tosylate in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery

NCT00110019 ·Status: COMPLETED ·Phase: PHASE3

An Open-Label Safety Study of API 31510 in a Topical Cream for in Situ Cutaneous Squamous Cell Carcinoma (SCCIS)

NCT00652080 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Radiotherapy in Combination With Atezolizumab in Locally Advanced Borderline Resectable or Unresectable Cutaneous SCC

NCT05085496 ·Status: RECRUITING ·Phase: PHASE1

Topical Use of 4,4'-Dihydroxybenzophenone-2,4-Dinitrophenylhydrazone (A-007) in the Treatment of Advanced Malignancies Including Kaposi's Sarcoma and Lymphoproliferative Disorders

NCT00002153 ·Status: COMPLETED ·Phase: PHASE1

7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)

NCT00031681 ·Status: COMPLETED ·Phase: PHASE1

Phase Ib/II of TG4001 and Avelumab in HPV16 Positive R/M Cancers

NCT03260023 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2

Phase 2 Study of the Poly(ADP-Ribose) Polymerase Inhibitor E7016 in Combination With Temozolomide in Subjects With Wild Type BRAF Stage IV or Unresectable Stage III Melanoma

NCT01605162 ·Status: TERMINATED ·Phase: PHASE2

S0011, Gene Therapy & Surgery Followed by Chemo & RT in Newly Diagnosed Cancer of the Mouth or Throat

NCT00017173 ·Status: TERMINATED ·Phase: PHASE2

Treatment for Subjects With Unresectable Stage III or Stage IV Melanoma

NCT00110994 ·Status: COMPLETED ·Phase: PHASE2